Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P K Pattengale

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Cancer Research|August 15, 1992
Restricted oncogenicity of BCR/ABL p190 in transgenic miceJ W Voncken, S Griffiths, M F Greaves, et al.
Natural Immunity|May 1, 1993
Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicityG M Gersuk, R Carmel, S Pattamakom, et al.
The American Journal of Pathology|June 1, 1982
Immunopathology of B-cell lymphomas induced in C57BL/6 mice by dualtropic murine leukemia virus (MuLV)P K Pattengale, C R Taylor, P Twomey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1988
Characterization of lymphoid tumors induced by a recombinant murine retrovirus carrying the avian v-myc oncogene. Identification of novel (B-lymphoid) tumors in the thymusB K Brightman, K G Chandy, R H Spencer, et al.
Scandinavian Journal of Immunology|May 1, 1991
Inhibition of human natural killer cell activity by platelet-derived growth factor (PDGF). III. Membrane binding studies and differential biological effect of recombinant PDGF isoformsG M Gersuk, B Westermark, A J Mohabeer, et al.
Journal of the National Cancer Institute|June 1, 1976
Surface immunoglobulin on leukemic, leukemoid, and normal granulocytesP K Pattengale, B K Schneider, J W Parker, et al.
Blood|September 15, 1993
Establishment and characterization of a human mixed-lineage, T-lymphoid/myeloid cell line (USP-91)T Umiel, C W Rettenmier, S Siegel, et al.
International Journal of Cancer|May 15, 1986
Natural killer-cell immunodeficiency in patients with chronic myelogenous leukemia. I. Analysis of the defect using the monoclonal antibodies HNK-1 (LEU-7) and B73.1Y Fujimiya, A Bakke, W C Chang, et al.
The American Journal of Pathology|November 1, 1985
Multiparameter analyses of spontaneous nonthymic lymphomas occurring in NFS/N mice congenic for ecotropic murine leukemia virusesT N Fredrickson, H C Morse, R A Yetter, et al.
The American Journal of Pathology|July 1, 1989
Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenesP K Pattengale, T A Stewart, A Leder, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Cancer Research|August 15, 1992
Restricted oncogenicity of BCR/ABL p190 in transgenic miceJ W Voncken, S Griffiths, M F Greaves, et al.
Natural Immunity|May 1, 1993
Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicityG M Gersuk, R Carmel, S Pattamakom, et al.
The American Journal of Pathology|June 1, 1982
Immunopathology of B-cell lymphomas induced in C57BL/6 mice by dualtropic murine leukemia virus (MuLV)P K Pattengale, C R Taylor, P Twomey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1988
Characterization of lymphoid tumors induced by a recombinant murine retrovirus carrying the avian v-myc oncogene. Identification of novel (B-lymphoid) tumors in the thymusB K Brightman, K G Chandy, R H Spencer, et al.
Scandinavian Journal of Immunology|May 1, 1991
Inhibition of human natural killer cell activity by platelet-derived growth factor (PDGF). III. Membrane binding studies and differential biological effect of recombinant PDGF isoformsG M Gersuk, B Westermark, A J Mohabeer, et al.
Journal of the National Cancer Institute|June 1, 1976
Surface immunoglobulin on leukemic, leukemoid, and normal granulocytesP K Pattengale, B K Schneider, J W Parker, et al.
Blood|September 15, 1993
Establishment and characterization of a human mixed-lineage, T-lymphoid/myeloid cell line (USP-91)T Umiel, C W Rettenmier, S Siegel, et al.
International Journal of Cancer|May 15, 1986
Natural killer-cell immunodeficiency in patients with chronic myelogenous leukemia. I. Analysis of the defect using the monoclonal antibodies HNK-1 (LEU-7) and B73.1Y Fujimiya, A Bakke, W C Chang, et al.
The American Journal of Pathology|November 1, 1985
Multiparameter analyses of spontaneous nonthymic lymphomas occurring in NFS/N mice congenic for ecotropic murine leukemia virusesT N Fredrickson, H C Morse, R A Yetter, et al.
The American Journal of Pathology|July 1, 1989
Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenesP K Pattengale, T A Stewart, A Leder, et al.
Pageof 7